Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Lysaght

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Journal of the American Society of Nephrology : JASN|January 17, 2002
Maintenance dialysis population dynamics: current trends and long-term implicationsMichael J Lysaght
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 7, 2003
Immunosuppression, immunoisolation and cell therapyMichael J Lysaght
Tissue Engineering|May 5, 2005
California's Proposition 71Michael J Lysaght
Tissue Engineering. Part A|March 31, 2009
OriginsMichael J Lysaght, Janet Crager
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 20, 2008
Wearable artificial kidneys...2008. What's new?Stanley Shaldon, Michael J Lysaght
Tissue Engineering|March 11, 2004
Tissue engineering: the end of the beginningMichael J Lysaght, Anne L Hazlehurst
Tissue Engineering|July 15, 2003
Private sector development of stem cell technology and therapeutic cloningMichael J Lysaght, Anne L Hazlehurst
Tissue Engineering. Part A|March 13, 2008
Great expectations: private sector activity in tissue engineering, regenerative medicine, and stem cell therapeuticsMichael J Lysaght, Ana Jaklenec, Elizabeth Deweerd
Tissue Engineering|December 14, 2004
In vivo and in vitro degradation of urea and uric acid by encapsulated genetically modified microorganismsJill A O'Loughlin, Jan M Bruder, Michael J Lysaght
Journal of Biomaterials Science. Polymer Edition|January 15, 2005
Oral administration of biochemically active microcapsules to treat uremia: new insights into an old approachJill A O'Loughlin, Jan M Bruder, Michael J Lysaght
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Journal of the American Society of Nephrology : JASN|January 17, 2002
Maintenance dialysis population dynamics: current trends and long-term implicationsMichael J Lysaght
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 7, 2003
Immunosuppression, immunoisolation and cell therapyMichael J Lysaght
Tissue Engineering|May 5, 2005
California's Proposition 71Michael J Lysaght
Tissue Engineering. Part A|March 31, 2009
OriginsMichael J Lysaght, Janet Crager
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 20, 2008
Wearable artificial kidneys...2008. What's new?Stanley Shaldon, Michael J Lysaght
Tissue Engineering|March 11, 2004
Tissue engineering: the end of the beginningMichael J Lysaght, Anne L Hazlehurst
Tissue Engineering|July 15, 2003
Private sector development of stem cell technology and therapeutic cloningMichael J Lysaght, Anne L Hazlehurst
Tissue Engineering. Part A|March 13, 2008
Great expectations: private sector activity in tissue engineering, regenerative medicine, and stem cell therapeuticsMichael J Lysaght, Ana Jaklenec, Elizabeth Deweerd
Tissue Engineering|December 14, 2004
In vivo and in vitro degradation of urea and uric acid by encapsulated genetically modified microorganismsJill A O'Loughlin, Jan M Bruder, Michael J Lysaght
Journal of Biomaterials Science. Polymer Edition|January 15, 2005
Oral administration of biochemically active microcapsules to treat uremia: new insights into an old approachJill A O'Loughlin, Jan M Bruder, Michael J Lysaght
Pageof 2